Chronic, noncommunicable diseases (NCDs) have surpassed infectious diseases as the primary cause of death and disability in most developing nations. Nowhere is this more evident than in China where NCDs account for 80% of all deaths and skyrocketing medical costs. Driving the escalation of NCDs are high rates of tobacco use, longer life spans, and changes in the traditional Chinese diet and lifestyle bolstered by unprecedented economic growth and the new global culture. Despite the epidemic of NCDs, few evidencebased interventions either to prevent or retard their progression exist in China. We present a case for the development and adoption of such strategies as effective tools to combat China's greatest health threat. Finally, we offer an example of a collaborative network linking Chinese public health and academic institutions with US researchers to promote the translation of western evidence-based interventions that fully incorporate local knowledge, culture, and capacity.
KeywordsNoncommunicable disease, Tobacco control, China, Evidence-based As low-and middle-income countries industrialize, urbanize, and integrate features of western culture with their traditional lifestyle, rates of noncommunicable diseases (NCDs) rise and portend alarming trends for the future. Globally, 35 million deaths annually are attributable to cardiovascular diseases (CVDs), chronic respiratory diseases, diabetes, and cancer with 80% of these occurring in developing nations [1]. In resource-poor developing nations where healthcare systems are often woefully underfunded, understaffed, and in flux, population-based approaches to combating NCDs may produce the greatest and most cost-effective results. The value of incorporating evidence-based, prevention-focused strategies that can be rolled out into communities has been demonstrated in developed nations [2]. To date, however, very few evidence-based approaches for health risk behavior modification have been utilized in economically developing nations [3].